Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 254 entries
View as:

EuroSIDA As An External Comparator To MOTIVATE Trials

Phase: N/A Priority: Normal
NCT ID: NCT01329783 Org: User:
Start: 04/30/07 End: 03/31/11 Due: 03/31/12

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)

Phase: N/A Priority: Normal
NCT ID: NCT01102972 Org: User:
Start: 04/30/10 End: 12/31/12 Due: 12/31/13

A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Phase: N/A Priority: Normal
NCT ID: NCT01563328 Org: User:
Start: 03/01/12 End: 05/01/12 Due: 05/01/13

Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02508064 Org: User:
Start: 08/03/15 End: 11/05/15 Due: 11/05/16

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

Phase: N/A Priority: Normal
NCT ID: NCT02938520 Org: User:
Start: 10/27/16 End: 12/31/25 Due: 12/31/26

GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03231943 Org: User:
Start: 09/19/17 End: 09/09/18 Due: 09/09/19

Drug Exposure Registry for GSK2248761, an Investigational NNRTI

Phase: N/A Priority: Normal
NCT ID: NCT01458132 Org: User:
Start: 07/29/11 End: 04/30/13 Due: 04/30/14

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

Phase: N/A Priority: Normal
NCT ID: NCT02422797 Org: User:
Start: 04/21/15 End: 05/25/23 Due: 05/25/24

A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT04871113 Org: User:
Start: 06/22/21 End: 09/21/23 Due: 09/21/24

Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254

Phase: N/A Priority: Normal
NCT ID: NCT04507321 Org: User:
Start: 09/24/20 End: 11/23/20 Due: 11/23/21

Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in Germany

Phase: N/A Priority: Normal
NCT ID: NCT02342769 Org: User:
Start: 02/19/15 End: 10/28/18 Due: 10/28/19

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Phase: N/A Priority: Normal
NCT ID: NCT01641809 Org: User:
Start: 08/06/12 End: 01/15/19 Due: 01/15/20

A Study to Investigate the Relative Bioavailability and Food Effect of an Oral Capsid Inhibitor Tablet Formulation Compared With Other Oral Tablet Formulations in Male and Female Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06168318 Org: User:
Start: 12/18/23 End: 06/03/24 Due: 06/03/25

Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1)

Phase: N/A Priority: Normal
NCT ID: NCT04233047 Org: User:
Start: - End: - Due: -

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01593046 Org: User:
Start: 05/31/12 End: 11/30/13 Due: 11/30/14

Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)

Phase: N/A Priority: Normal
NCT ID: NCT04001803 Org: User:
Start: 07/08/19 End: 03/18/22 Due: 03/18/23

GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00257621 Org: User:
Start: 10/31/04 End: 01/31/07 Due: 01/31/08

Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1

Phase: N/A Priority: Normal
NCT ID: NCT01009814 Org: User:
Start: 11/23/09 End: 06/25/10 Due: 06/25/11

A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01101893 Org: User:
Start: 04/30/10 End: 06/30/10 Due: 06/30/11

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06033547 Org: User:
Start: 09/12/23 End: 07/25/25 Due: 07/25/26

A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF

Phase: N/A Priority: Normal
NCT ID: NCT05911360 Org: User:
Start: 07/07/23 End: 02/16/26 Due: 02/16/27

A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany

Phase: N/A Priority: Normal
NCT ID: NCT02076386 Org: User:
Start: 03/04/14 End: 07/05/17 Due: 07/05/18

Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02082808 Org: User:
Start: 03/31/14 End: 05/31/14 Due: 05/31/15

Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00708110 Org: User:
Start: 06/30/08 End: 08/31/08 Due: 08/31/09

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01199731 Org: User:
Start: 10/05/10 End: 07/19/11 Due: 07/19/12